You may qualify to participate in a clinical study
Researchers in the United States are looking for adults who experience motion sickness for a clinical study for a new investigational medication for motion sickness. Qualified participants will be reimbursed for their time and participation.
You may qualify to join the study if you:
The study duration is generally three visits consisting of a screening visit, a travel assessment, and an end of study visit.
The travel portion of the study will include a boat trip to assess your symptoms of motion sickness in this situation.
We adhere to a strict privacy policy that protects any information you share with us. We will not disclose your name or other personally identifiable information without your permission.
This study is sponsored by
Vanda Pharmaceuticals
2200 Pennsylvania Ave
NW Suite 300E
Washington, DC 20037
Tel: 202-734-3400
Fax: 202-296-1450
© 2021 Vanda Pharmaceuticals